CIPLA recalls Esomeprazole Magnesium for Delayed-Release Oral Suspension 40mg, packaged in unit dose packets, Rx only, Manufactured by
Recalled January 6, 2021 · FDA recall D-0183-2021 · CIPLA
Hazard
Cross- contamination with other products: The excipient, Crospovidone, NF is contaminated with theophylline · FDA Class II
Units
6,491 packets
Sold at
U.S.A. Nationwide
Description
Cross- contamination with other products: The excipient, Crospovidone, NF is contaminated with theophylline
Product
Esomeprazole Magnesium for Delayed-Release Oral Suspension 40mg, packaged in unit dose packets, Rx only, Manufactured by: Cipla Ltd., Kurkumbh, India, Manufactured for: Cipla USA, Inc. 10 Independence Boulevard, Suite 300 Warren, NJ 07059 NDC 69097-529-34
Manufacturer(s)
CIPLA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →